Mint Tower Capital Management B.V. Seagen Inc. Transaction History

Mint Tower Capital Management B.V.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $770,061 - $869,179	-4,021 Reduced 80.08%	1,000 $212,000
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $529,332 - $581,831	2,821 Added 128.23%	5,021 $966,000
Q1 2023 May 09, 2023	BUY	$127.59 - $203.08 $280,698 - $446,776	2,200 New	2,200 $445,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.